FDA Forms Internal Nanotechnology Task Force
August 9, 2006. Acting Commissioner of Food and Drugs Andrew C. von Eschenbach, M.D., announced the Food and Drug Administration (FDA) is forming a new task force to determine regulatory approaches to encourage the continued development of innovative, safe, and effective FDA-regulated products that use nanotechnology materials.
The task force will identify and recommend ways to address any knowledge or policy gaps that exist so as to better enable the agency to evaluate possible adverse health effects from FDA-regulated products that use nanotechnology materials. Product-specific, nanotechnology-related issues will be addressed on an ongoing basis